- Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Academic Article GET IT
SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer.
Times cited: 31